Press release
Emerging Growth Patterns Driving Expansion in the Oral Thin Films Market
Oral Thin Films Market
Market Size and Growth Outlook in the Oral Thin Films Market
The oral thin films market is projected to expand swiftly, reaching a valuation of $9.82 billion by 2030. This growth corresponds to a compound annual growth rate (CAGR) of 14.4%. Several factors contribute to this anticipated rise, including the increasing use of personalized medicine delivery systems and rising investments in new polymer formulations. Additionally, the broadening availability of over-the-counter (OTC) oral therapeutics, heightened attention to pediatric and geriatric healthcare, and growing demand for treatments that act quickly are all fueling this market's growth. Notable trends expected to shape the industry include the widespread adoption of rapid-acting drug delivery films, a preference for patient-friendly dosage forms, advances in polymer-based film technologies, expansion in OTC oral film products, and a concentrated effort to improve bioavailability.
Download a free sample of the oral thin films market report:
https://www.thebusinessresearchcompany.com/report/oral-thin-films-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Leading Companies Driving the Oral Thin Films Market Forward
Several prominent companies are actively shaping the oral thin films market landscape, including ZIM Laboratories Limited, Cure Pharmaceutical Holding Corp., IntelGenx Corp., Aquestive Therapeutics Inc., BioDelivery Sciences International Inc., Indivior PLC, LTS Lohmann Therapie-Systeme AG, Tesa Labtec GmbH, APR Applied Pharma Research SA, NAL Pharma, Panacea Biotec Ltd., Shilpa Therapeutics Pvt. Ltd., LIVKON Pharmaceuticals Pvt. Ltd., Kyu Kyu Pharmaceutical Co. Ltd., Seoul Pharma Co. Ltd., Adare Pharmaceuticals Inc., Sumitomo Dainippon Pharma Co. Ltd., Sunovion Pharmaceuticals Inc., MonoSol Rx LLC, and C.L. Pharm Co. Ltd.
A notable development occurred in April 2023 when DifGen Pharmaceuticals LLC, a US-based healthcare technology firm, acquired Aveva Drug Delivery Services Inc. Although the financial details were undisclosed, this acquisition aimed to enhance DifGen's research and manufacturing capabilities for complex drug delivery dosage forms. With this move, DifGen sought to establish a US-based manufacturing hub, boost supply chain resilience, and continue providing affordable, high-quality lifesaving medicines. Aveva Drug Delivery Services specializes in manufacturing transdermal delivery systems (TDS) and oral dissolvable films (ODF).
View the full oral thin films market report:
https://www.thebusinessresearchcompany.com/report/oral-thin-films-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Emerging Trends Shaping the Future of Oral Thin Films
The acquisition of Aveva Drug Delivery Services by DifGen Pharmaceuticals highlights a strategic shift toward strengthening oral thin film and transdermal delivery technologies. This development reflects the growing focus on versatile and efficient drug delivery platforms that can cater to various patient needs and improve therapeutic outcomes. Such industry moves underscore the increasing importance of cutting-edge manufacturing capabilities and innovation to keep pace with rising market demands.
Key Segments Defining the Global Oral Thin Films Market
This report categorizes the oral thin films market into several primary segments to offer a clearer understanding of its structure and opportunities:
1) By Type: Sublingual Film and Fast Dissolving Dental/Buccal Film
2) By Disease Indication: Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting, and Other Disease Indications
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Other Distribution Channels
Further subdivisions include:
- Sublingual Film segment: divided into Drug Delivery Films and Nutritional Supplement Films
- Fast Dissolving Dental/Buccal Film segment: split between Over-the-Counter (OTC) Products and Prescription Products
These classifications help identify specific market niches and cater to diverse therapeutic and commercial needs within the oral thin films sector.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Emerging Growth Patterns Driving Expansion in the Oral Thin Films Market here
News-ID: 4472186 • Views: …
More Releases from The Business Research Company
Saphnelo Market Overview: Major Segments, Strategic Developments, and Leading Co …
The Saphnelo market is poised for significant growth over the coming years, driven by several advancements in disease management and treatment technologies. This report explores the market's expansion potential, key players, and emerging trends shaping its future. Let's dive into the details of market size, influential factors, leading companies, and the main segments covered in this field.
Saphnelo Market Growth Outlook Through 2030
The anticipated rise in the Saphnelo market can…
Rystiggo Market Analysis: Segmentation, Major Trends, and Competitive Overview
The Rystiggo market is gaining significant attention as advancements in autoimmune treatments continue to evolve. With growing investments and innovative therapies shaping the landscape, this market is positioned for notable growth over the next several years. Let's delve into the current market size projections, key drivers, leading companies, emerging trends, and segmentation within the Rystiggo industry.
Projected Growth Trajectory of the Rystiggo Market by 2030
The expected growth during the forecast…
Leading Companies Fueling Growth and Innovation in the Rotateq Market
The Rotateq market is witnessing promising developments as efforts to enhance vaccination coverage and healthcare infrastructure gain momentum worldwide. With advancements in vaccine technology and growing focus on infant health, the market is set to experience considerable growth over the next several years. Let's explore the market size forecasts, key players, and the main segments shaping this sector.
Projected Market Size and Growth Drivers in the Rotateq Market
The expected growth…
Growth Patterns, Segment Analysis, and Competitive Approaches Influencing the Ri …
The Rixubis market is gaining significant momentum as advancements in hemophilia treatment continue to evolve. Innovations in clotting factor therapies and personalized care approaches are driving substantial interest in this sector. Let's explore the market's projected size, key growth drivers, leading companies, and segmentation to understand the opportunities ahead.
Projected Growth and Market Size of the Rixubis Industry by 2030
The expansion anticipated during the forecast period is largely due to…
More Releases for Pharm
Fenbendazole Market Size, Share and Forecast By Key Players-Jin Dun Pharm, Shand …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Fenbendazole market is anticipated to grow at a compound annual growth rate (CAGR) of 16.05% between 2024 and 2031. The market is expected to grow to USD 68 Billion by 2024. The valuation is expected to reach USD 192.77 Billion by 2031.
The fenbendazole market is experiencing notable growth due to increasing awareness of parasitic infections in both…
Revolutionizing Revenue: Dexlansoprazole Sustained Release Capsule Market Trends …
Worldwide Market Reports announces the publication of its most recently generated research report titled, "Dexlansoprazole Sustained Release Capsule Market - Forecast to 2030", which offers a holistic view of the Dexlansoprazole Sustained Release Capsule market through systematic segmentation that covers every aspect of the target market. Dexlansoprazole Sustained Release Capsule with 100+ market data Tables, Pie Chat, Graphs, and Figures spread through Pages and easy-to-understand detailed analysis. The information is…
Paromomycin Sulfate Market 2030 by Top 10+ Players Pfizer,, Changrui Pharm,, ERF …
Paromomycin Sulfate is an antibiotic used to treat infections caused by certain parasites. It is commonly used to treat visceral leishmaniasis, a serious parasitic disease that affects the internal organs. The market for Paromomycin Sulfate is relatively small compared to other antibiotics, as it is primarily used to treat a specific type of parasitic infection. However, the market for Paromomycin Sulfate is expected to grow as the incidence of visceral…
Fosfomycin Market to Witness Huge Growth by 2026 | Northeast Pharm, Ercros, Shin …
The Latest Released Fosfomycin market study has evaluated the future growth potential of Global Fosfomycin market and provides information and useful stats on market structure and size. The report is intended to provide market intelligence and strategic insights to help decision makers take sound investment decisions and identify potential gaps and growth opportunities. Additionally, the report also identifies and analyses changing dynamics, emerging trends along with essential drivers, challenges, opportunities…
Clopidol Market updates, demand analysis, and expected growth forecast 2021-2027 …
Global “Clopidol” Market Size, Status, and Forecast 2021-2027. In-depth research accumulated to offer Latest insights about acute features of the global Clopidol market. This report provides a detailed overview of key factors in the Clopidol Market and factors such as driver, restraint, past and current trends, regulatory scenarios and technology development. The effect of the COVID-19 outbreak at the enterprise turned into completely assessed. Fully chance evaluation and enterprise recommendations…
Paromomycin Market updates, demand analysis, and expected growth forecast 2021-2 …
The new study on the Global “Paromomycin Market” 2021-2027 analyzes the crucial capabilities, key infrastructures, major organizations, evaluates measures to attain potential success in the Paromomycin industry. Because of the in-depth overview of the Global Paromomycin market, the recent papers allow investors, traders, and manufacturers to plan some innovative techniques, and meanwhile, align them with operational and commercial enterprise models. Additionally, the Paromomycin market report offers crucial facets at the…
